A detailed history of Ameriprise Financial Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 79,041 shares of GH stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,041
Previous 72,029 9.73%
Holding current value
$2.39 Million
Previous $2.08 Million 12.88%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $156,367 - $254,465
7,012 Added 9.73%
79,041 $1.81 Million
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $774,365 - $1.53 Million
48,187 Added 202.11%
72,029 $2.08 Million
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $7.85 Million - $12.3 Million
-458,154 Reduced 95.05%
23,842 $491,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $1.36 Million - $1.86 Million
62,993 Added 15.03%
481,996 $13 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $834,991 - $1.29 Million
32,364 Added 8.37%
419,003 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $8.1 Million - $14.7 Million
386,639 New
386,639 $13.8 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $4,409 - $6,161
101 Added 1.03%
9,917 $534,000
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $137,961 - $370,274
4,787 Added 95.19%
9,816 $396,000
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $183,205 - $381,560
-3,797 Reduced 43.02%
5,029 $333,000
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $176,266 - $239,294
1,987 Added 29.05%
8,826 $883,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $1.36 Million - $1.82 Million
-13,797 Reduced 66.86%
6,839 $855,000
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $1.09 Million - $1.65 Million
-9,971 Reduced 32.58%
20,636 $2.56 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $1.82 Million - $2.57 Million
-14,345 Reduced 31.91%
30,607 $4.67 Million
Q4 2020

Feb 12, 2021

SELL
$99.96 - $135.93 $68.8 Million - $93.6 Million
-688,302 Reduced 93.87%
44,952 $5.79 Million
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $16.7 Million - $23.2 Million
-207,756 Reduced 22.08%
733,254 $81.9 Million
Q2 2020

Aug 14, 2020

SELL
$60.49 - $97.5 $21.9 Million - $35.3 Million
-361,541 Reduced 27.76%
941,010 $76.3 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $7.72 Million - $11.6 Million
-130,687 Reduced 9.12%
1,302,551 $90.6 Million
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $5.83 Million - $8.11 Million
97,936 Added 7.33%
1,433,238 $112 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $2.24 Million - $3.94 Million
35,730 Added 2.75%
1,335,302 $85.2 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $47.8 Million - $68.1 Million
747,385 Added 135.35%
1,299,572 $112 Million
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $15.9 Million - $45.5 Million
464,153 Added 527.24%
552,187 $42.3 Million
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $2.57 Million - $4.06 Million
88,034 New
88,034 $3.31 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.09B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.